ERBB2 and breast carcinoma: The plant‐produced TMab (PMT) showed similar HER2 binding affinity and tumour‐killing effectiveness to a commercial TMab in in vitro anti‐proliferation assays performed on HER2‐positive breast cancer cell lines.